170 related articles for article (PubMed ID: 7827407)
1. Structural features in heparin which modulate specific biological activities mediated by basic fibroblast growth factor.
Ishihara M; Shaklee PN; Yang Z; Liang W; Wei Z; Stack RJ; Holme K
Glycobiology; 1994 Aug; 4(4):451-8. PubMed ID: 7827407
[TBL] [Abstract][Full Text] [Related]
2. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
Ishihara M
Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
[TBL] [Abstract][Full Text] [Related]
3. Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor.
Ishihara M; Tyrrell DJ; Stauber GB; Brown S; Cousens LS; Stack RJ
J Biol Chem; 1993 Mar; 268(7):4675-83. PubMed ID: 8444841
[TBL] [Abstract][Full Text] [Related]
4. Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor.
Tyrrell DJ; Ishihara M; Rao N; Horne A; Kiefer MC; Stauber GB; Lam LH; Stack RJ
J Biol Chem; 1993 Mar; 268(7):4684-9. PubMed ID: 8444842
[TBL] [Abstract][Full Text] [Related]
5. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
Jayson GC; Gallagher JT
Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
[TBL] [Abstract][Full Text] [Related]
6. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.
Aviezer D; Levy E; Safran M; Svahn C; Buddecke E; Schmidt A; David G; Vlodavsky I; Yayon A
J Biol Chem; 1994 Jan; 269(1):114-21. PubMed ID: 8276782
[TBL] [Abstract][Full Text] [Related]
7. Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
Coltrini D; Rusnati M; Zoppetti G; Oreste P; Grazioli G; Naggi A; Presta M
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):583-90. PubMed ID: 7980421
[TBL] [Abstract][Full Text] [Related]
8. Endothelial and fibroblast cell-derived heparan sulphate bind with differing affinity to basic fibroblast growth factor.
Pye DA; Kumar S
Biochem Biophys Res Commun; 1998 Jul; 248(3):889-95. PubMed ID: 9704022
[TBL] [Abstract][Full Text] [Related]
9. Structure of a heparan sulphate oligosaccharide that binds to basic fibroblast growth factor.
Habuchi H; Suzuki S; Saito T; Tamura T; Harada T; Yoshida K; Kimata K
Biochem J; 1992 Aug; 285 ( Pt 3)(Pt 3):805-13. PubMed ID: 1497618
[TBL] [Abstract][Full Text] [Related]
10. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate.
Turnbull JE; Fernig DG; Ke Y; Wilkinson MC; Gallagher JT
J Biol Chem; 1992 May; 267(15):10337-41. PubMed ID: 1587820
[TBL] [Abstract][Full Text] [Related]
11. Heparin structure and interactions with basic fibroblast growth factor.
Faham S; Hileman RE; Fromm JR; Linhardt RJ; Rees DC
Science; 1996 Feb; 271(5252):1116-20. PubMed ID: 8599088
[TBL] [Abstract][Full Text] [Related]
12. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity.
Pye DA; Vives RR; Turnbull JE; Hyde P; Gallagher JT
J Biol Chem; 1998 Sep; 273(36):22936-42. PubMed ID: 9722514
[TBL] [Abstract][Full Text] [Related]
13. Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
Presta M; Statuto M; Isacchi A; Caccia P; Pozzi A; Gualandris A; Rusnati M; Bergonzoni L; Sarmientos P
Biochem Biophys Res Commun; 1992 Jun; 185(3):1098-107. PubMed ID: 1378264
[TBL] [Abstract][Full Text] [Related]
14. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
15. Binding of heparin/heparan sulfate to fibroblast growth factor receptor 4.
Loo BM; Kreuger J; Jalkanen M; Lindahl U; Salmivirta M
J Biol Chem; 2001 May; 276(20):16868-76. PubMed ID: 11278860
[TBL] [Abstract][Full Text] [Related]
16. Multivalent ligand-receptor binding interactions in the fibroblast growth factor system produce a cooperative growth factor and heparin mechanism for receptor dimerization.
Pantoliano MW; Horlick RA; Springer BA; Van Dyk DE; Tobery T; Wetmore DR; Lear JD; Nahapetian AT; Bradley JD; Sisk WP
Biochemistry; 1994 Aug; 33(34):10229-48. PubMed ID: 7520751
[TBL] [Abstract][Full Text] [Related]
17. Importance of size and sulfation of heparin in release of basic fibroblast growth factor from the vascular endothelium and extracellular matrix.
Ishai-Michaeli R; Svahn CM; Weber M; Chajek-Shaul T; Korner G; Ekre HP; Vlodavsky I
Biochemistry; 1992 Feb; 31(7):2080-8. PubMed ID: 1536850
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the heparin-binding domains of human basic fibroblast growth factor alter its biological activity.
Heath WF; Cantrell AS; Mayne NG; Jaskunas SR
Biochemistry; 1991 Jun; 30(22):5608-15. PubMed ID: 2036431
[TBL] [Abstract][Full Text] [Related]
19. Heparin and heparan sulphate protect basic fibroblast growth factor from non-enzymic glycosylation.
Nissen NN; Shankar R; Gamelli RL; Singh A; DiPietro LA
Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):637-42. PubMed ID: 10051433
[TBL] [Abstract][Full Text] [Related]
20. Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor.
Walker A; Turnbull JE; Gallagher JT
J Biol Chem; 1994 Jan; 269(2):931-5. PubMed ID: 8288646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
